Mustang Bio, Inc. (MBIO)

Mustang Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-51.6	-77.53	-66.37	-60.02	-46.39
Depreciation & Amortization	2.23	3.03	2.31	1.79	1.37
Share-Based Compensation	0.57	2.28	3.31	2.99	2.66
Other Operating Activities	-0.67	7.15	7.09	17.92	8.78
Operating Cash Flow	-49.48	-65.07	-53.67	-37.32	-33.58
Capital Expenditures	5.94	-2.59	-3.99	-1.93	-2.35
Change in Investments	0	0	0	0	17.6
Other Investing Activities	-0.05	-0.37	-1.38	-2.49	-1.35
Investing Cash Flow	5.89	-2.95	-5.37	-4.41	13.91
Share Issuance / Repurchase	4.74	6.83	72.23	97.38	54.14
Debt Issued / Paid	-30.38	30	0	-15.75	13.61
Other Financing Activities	-0.45	-2.77	-1.38	-3.51	-2.63
Financing Cash Flow	-26.08	34.06	70.85	78.12	65.12
Net Cash Flow	-69.67	-33.96	11.81	36.39	45.44
Free Cash Flow	-43.54	-67.65	-57.65	-39.24	-35.93
Free Cash Flow Per Share	-5.06	-8.80	-9.84	-11.19	-14.94

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).